Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia. 

News

September 15, 2011 — Very positive results were reported in the first account of a clinical study evaluating the ...

Home September 15, 2011
Home
News

September 13, 2011 – An U.S. Food and Drug Administration’s (FDA) will discuss recommendations for Cook Medical Zilver ...

Home September 13, 2011
Home
News

September 8, 2011 – Abbott announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety ...

Home September 08, 2011
Home
News

September 1, 2011 ­– Medrad Inc. has acquired Pathway Medical Technologies Inc. to strength its vascular interventional ...

Home September 01, 2011
Home
News

August 29, 2011 — The Guidelines on Peripheral Artery Disease (PAD) are the first document produced by the European ...

Home August 29, 2011
Home
News

August 25, 2011 – Two articles in the Society of Interventional Radiology (SIR)'s flagship publication, the Journal of ...

Home August 25, 2011
Home
News

August 25, 2011 – ­ The Munich biotech company apceth started its first Phase I/II clinical study on somatic cell ...

Home August 25, 2011
Home
News

August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent ...

Home August 10, 2011
Home
News

August 5, 2011 — BridgePoint Medical Inc., a Minnesota-based medical device company, has enrolled its first patient in ...

Home August 05, 2011
Home
News

August 5, 2011 — Vessix Vascular Inc. (formerly known as Minnow Medical Inc.), developer of novel percutaneous ...

Home August 05, 2011
Home
Technology

August 2, 2011 – The U.S. Food and Drug Administration said it recently cleared Abbott Vascular’s RX Herculink Elite ...

Home August 02, 2011
Home
News

July 20, 2011 — IDEV Technologies Inc. announced the completion of enrollment in the SUPERB trial, a U.S. Food and Drug ...

Home July 20, 2011
Home
News

July 18, 2011 — NSVascular Inc., a newly formed subsidiary of NeuroSigma Inc., has signed an exclusive license with the ...

Home July 18, 2011
Home
Feature | Dave Fornell

The goal of treating peripheral artery disease (PAD) in the superficial femoral artery (SFA) is limb salvage and ...

Home July 15, 2011
Home
News

June 29, 2011 – For the first time, human blood vessels grown in a laboratory from donor skin cells have been ...

Home June 29, 2011
Home
Subscribe Now